Evidence map›Paper›PMID 38808478›Full record

ArticleJournal of applied behavior analysis2024

Examination of clinical variables affecting resurgence: A reanalysis of 46 applications.

Brianna Laureano, Joel Ringdahl, John M Falligant

Abstract read
In one paragraph

Article in Journal of applied behavior analysis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. A scoping review of consecutive controlled case series studies.Journal of applied behavior analysis · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Brianna LaureanoDepartment of Behavioral Psychology, Kennedy Krieger Institute, Baltimore, MD, USA.ORCID 0000-0001-7361-0609
Joel RingdahlCenter for Autism and Behavioral Education Research, The University of Georgia, Athens, Georgia, USA.ORCID 0000-0003-4282-5150
John M FalligantDepartment of Behavioral Psychology, Kennedy Krieger Institute, Baltimore, MD, USA.ORCID 0000-0002-0062-9074

Funding

Harnessing Communication Preferences to Enhance Its Persistence and Mitigate Relapse of Challenging BehaviorR01HD069377 · NICHD · UNIVERSITY OF GEORGIA · PI Joel Ringdahl, Kelly Michele Schieltz · 2012 to 2026
$4.6M
Eunice Kennedy Shriver National Institute of Child Health and Human Development R01HD069377NICHD NIH HHS R01 HD069377
6 · The paper itself

Abstract

Despite the efficacy of behavioral interventions, resurgence of challenging behavior (e.g., aggression, self-injury) following successful treatment can still occur. Applied work has focused on identifying treatment-related variables thought to affect the occurrence and magnitude of resurgence. The current study describes the relation between several variables (i.e., phase duration, response rates in baseline and treatment, obtained rates of reinforcement, downshift in reinforcement step size) and resurgence in a retrospective consecutive controlled case series of 46 treatment applications for challenging behavior conducted in an inpatient setting. Only the downshift in reinforcement (e.g., schedule-thinning) step size was correlated with the magnitude of resurgence. These results are consistent with recent findings suggesting that treatment duration and other factors have inconsistent effects on resurgence of challenging behavior.

Indexed as

Behavior TherapyReinforcement, PsychologyAdolescentAdultAggressionChildFemaleHumansMaleMiddle AgedProblem BehaviorReinforcement ScheduleRetrospective StudiesSelf-Injurious BehaviorYoung Adultchallenging behaviorconsecutive controlled case seriesresurgenceretrospective analysis

Identifiers

PMID38808478
PMCPMC11260239

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.